Personal Genome Diagnostics Inc. (PGDx) – a leader in cancer genomics – is partnering with Eisai Co. Ltd. to develop a comprehensive liquid biopsy biomarker discovery solution for oncology, to be used by Eisai researchers at their Tsukuba Research Laboratory.